Dear Colleagues, I am honored to once again serve as a Guest Editor...
I am honored to once again serve as a Guest Editor for Foot and Ankle Quarterly. This Fall 2020 issue focuses on dermatology, specifically plantar hyperhidrosis and plantar psoriasis, and the articles, lectures and commentaries will provide you with a detailed review of basic knowledge, diagnosis and management of these two clinical entities.
Plantar psoriasis is a topic which all podiatric physicians should be familiar with, due to its significant effect on a patient’s quality of life. This issue will delve into the latest treatments, from topical to systemic. Many of our patients also suffer from plantar hyperhidrosis, and I hope that in these pages the reader will discover new treatment options beyond topical therapy.
The condensations and commentaries in this issue will offer up-to-date, peer-reviewed information on the nuances of both of these unique conditions, ranging from biologic therapy for nail psoriasis to the details of pitted keratolysis presentations. A number of other treatments are explored in the commentaries including iontophoresis, adalimumab and lumbar sympathectomy.
I hope that this issue assists you in your clinical practice, and as always it is a pleasure to play a part in your continued education in podiatric dermatology.
The ideas and opinions expressed in Foot and Ankle Quarterly are those of the authors and do not necessarily reflect those of the Editor or the Publisher. Publication of an advertisement or other product mentioned in Foot and Ankle Quarterly should not be construed as an endorsement of the product of the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The Publisher does not assume any responsibility for any injury and/or damage to any persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device or of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.
Data Trace Publishing Company Continuing Education Mission Statement
Data Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including lectures, feature articles, and condensations and commentaries on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.
Foot and Ankle Quarterly (FAQ) is a unique program designed to help today’s podiatric physician manage an ever-increasing flow of information. After completing the Foot and Ankle Quarterly, Volume 31 program, the learner should be better able to: develop and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to the diagnosis and treatment of podiatric disorders and societal issues and barriers, and; apply current trends, standards, and best practices into learner’s own practice.
Data Trace Publishing Company Continuing Education Accreditation Statement
Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 8 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.
Estimated time to complete activity: 8 hours Date of release: December 10, 2020 Expiration Date:December 10, 2023 (unless further validated and extended by provider). For amended dates of activity expiration, please see FAQ Activity Effective Dates at www.datatrace.com).
No commercial interest provided financial support for this continuing education activity.
Participants of Volume 31, Issue 3 will receive a maximum of 8 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 70% or more must be achieved on the written examination material. Any participant who does not pass the first time may take the exam one additional time (within 90 days of receipt of results). One retake test may be taken for a fee of $15. You will be responsible for notifying your state of the number of contact hours you have received.
Participants are required to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.
FINANCIAL DISCLOSURE INFORMATION
It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.
In addition to disclosing commercial relationships, faculty are advised of the following policies:
Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.
Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).
Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.
Data Trace Publishing Company has identified the option to disclose as follows:
The following authors have disclosed whether they or a member of their immediate family:
Will be receiving an honorarium for this activity
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author:
Received monetary or other significant research support
Are or had been a paid consultant
Are or had been a full-time or part-time employee
Are or had been a paid or unpaid member of an advisory or similar board
Are or had been a member or on the Board of Trustees
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies
n. Have no conflicts to disclose
Article Authors and Lecturers
Sara M. Bouraee, DPM (n.)
Keith C. Fleischman, DPM, MPT (n.)
Priscilla Z. Howie, DPM (n.)
Dusty R. Haverly, DPM (n.)
Sara Karamloo, DPM (n.)
Dia D. McCaughan, DPM (n.)
Keval Parikh, DPM (n.)
Adam Saleh, DPM (n.)
Joshua A. Sebag, DPM (n.)
Ashka Trivedi, DPM (n.)
Marija Ugrinich, DPM (n.)
Elena K. Wellens, DPM (n.)
Sydney K. Yau, DPM (n.)
Tracey C. Vlahovic, DPM, FFPM, RCPS (Glasg) (1. Data Trace Publishing Company)
Tracey C. Vlahovic, DPM, FFPM, RCPS (Glasg)
Clinical Professor, Temple University School of Podiatric Medicine, Dept of Podiatric Medicine, Philadelphia, PA; Fellow, Faculty of Podiatric Medicine, Royal College of Physicians and Surgeons (Glasg)
Sara M. Bouraee, DPM
Managing Member, Hampton Roads Foot and Ankle, Williamsburg, VA; Fellow, American College of Foot and Ankle Surgeons
Keith C. Fleischman, DPM, MPT
Managing Partner, Mount Joy Foot and Ankle, Lancaster General Wound Care Center; Adjunct Faculty, Department of Orthopedics, Department of Surgery, Temple University School of Podiatric Medicine, Phila- delphia, PA; Surgical case reviewer, American Board of Foot and Ankle Surgery; Diplomate, American Board of Podiatric Medicine
Priscilla Z. Howie, DPM
Owner, Restore Foot and Ankle Center, Medford, NJ; Diplomate, American Board of Podiatric Medicine
Dusty R. Haverly, DPM, FACFAS
OAA Orthopaedic Specialists, Allentown, PA; Faculty, St. Luke’s University Hospital, Bethlehem, PA. Fellow, American College of Foot and Ankle Surgeons
Sara Karamloo, DPM
Kaiser Permanente Northern California, San Jose, CA; Diplomate, American Board of Podiatric Medicine
Dia D. McCaughan, DPM
Owner, Quarryville Family Foot Care, Quarryville, PA; Clinical Staff, Lancaster General Hospital, Lancaster, PA; University of Pennsylvania Medical Center Lititz, Lititz, PA: Fellow, American College of Foot and Ankle Surgeons; Fellow, American Society of Podiatric Surgeons; Fellow, Academy of Physicians in Wound Healing; Board member, PA Board of Podiatry
Keval Parikh, DPM, AACFAS, FAPWHc
Associate Physician, Brucato Foot and Ankle Surgery; Attending Physician, Pediatric Foot and Ankle Fellow- ship; Attending Podiatric Physician, Hackensack Medical Center; Attending Podiatric Physician, Overlook Medical Center; Fellow, Academy of Physicians in Wound Healing; Associate, American College of Foot and Ankle Surgeons
M. Adam Saleh, DPM
Gentle Touch Foot Care, East Orange, NJ; Associate, American College of Foot and Ankle Surgery; Associate, American Board of Podiatric Medicine
Joshua A. Sebag, DPM
Chief Resident, Podiatric Medicine and Surgery, Advent Health, East Orlando, FL
Ashka Trivedi, DPM
Scholl Foot and Ankle Center at Rosalind Franklin University Health Clinics, North Chicago, IL; Scholl College Faculty, Assistant Professor and Clinical Instructor, Applied Biomechanics and Surgery Department
Marija Ugrinich DPM
Attending Physician, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA; Adjunct Professor, Temple University School of Podiatric Medicine, Philadelphia, PA; Fellow, American College of Foot and Ankle Surgeons
Elena K. Wellens, DPM
Associate Physician, Rothman Orthopaedics, Philadelphia, PA; Instructor, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Fellow, American College of Foot and Ankle Surgeons
Sydney K. Yau, DPM
Assistant Professor, Scholl College of Podiatric Medicine, North Chicago, IL; Fellow, American College of Foot and Ankle Surgeons; Diplomate, American Board of Podiatric Medicine
In This Issue:
FEATURE ARTICLE: A Review of Diagnosis and Management of Plantar Hyperhidrosis and Plantar Psoriasis
Tracey C. Vlahovic, DPM
CONDENSATIONS and COMMENTARIES
Iontophoresis for Palmar and Plantar Hyperhidrosis
Commentary by Elena K. Wellens, DPM
A Systematic Review and Meta-Analysis to Evaluate the Efficacy of Lumbar Sympathectomy for Plantar Hyperhidrosis
Commentary by Keith C. Fleischman, DPM
The Etiology, Diagnosis, and Management of Hyperhidrosis: A Comprehensive Review: Etiology and Clinical Work-Up
Commentary by M. Adam Saleh, DPM
Sweaty Feet in Adolescents-Early Use of Botulinum Type A Toxin in Juvenile Plantar Hyperhidrosis
Commentary by Sara Karamloo, DPM
Pitted Keratolysis: A Study of Various Clinical Manifestations
Commentary by Keval Parikh, DPM
Plantar Hyperhidrosis: An Overview
Commentary by Dusty R. Haverly, DPM
Diagnosis and Treatment Options for Inflammatory Skin Conditions of the Lower Extremity
Commentary by Sydney K. Yau, DPM
Adalimumab for Nail Psoriasis: Efficacy and Safety from the First 26 Weeks of a Phase 3, Randomized, Placebo-Controlled Trial
Commentary by Priscilla Z. Howie, DPM and Sara M. Bouraee, DPM
Prevalence of Psoriasis Phenotypes among Men and Women in the USA
Commentary by Ashka Trivedi, DPM
A Study of the Histopathology of Palmo-Plantar Psoriasis and Hyperkeratotic Palmo-Plantar Dermatitis
Commentary by Dia D. McCaughan, DPM
Subclinical Enthesopathy in Patients with Psoriasis and its Association with Other Disease Parameters: A Power Doppler Ultrasonographic Study
Commentary by Marija Ugrinich, DPM
Plantar Forefoot Pressures in Psoriatic Arthritis-Related Dactylitis: An Exploratory Study
Commentary by Joshua A. Sebag, DPM
Safety and Efficacy of Adalimumab in the Treatment of Moderate to Severe Palmo-Plantar Psoriasis: An Open Label Study
Commentary by Ashka Trivedi, DPM
AUDIO LECTURE 1: Plantar Hyperhidrosis: Diagnosis and Management
Tracey C. Vlahovic, DPM
AUDIO LECTURE 2: Plantar Psoriasis: Diagnosis and Management
Tracey C. Vlahovic, DPM